WALTHAM, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of ...
Repligen Corporation announced the launch of its CTech™ SoloVPE® PLUS System, an advanced UV-based Variable Pathlength Technology designed for biopharmaceutical manufacturers. This system enhances ...
Repligen has launched the KrosFlo RS 10, a bench-scale tangential flow filtration (TFF) system. According to the company, the system was designed to satisfy the growing shift toward personalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results